Clik here to view.
Solasia and Lee’s Pharma Announce License, Promotion and Supply Agreement...
TOKYO & HONG KONG Solasia Pharma K.K. (Headquarters: Tokyo, Japan, President: Yoshihiro Arai, hereinafter “Solasia”) and Lee’s Pharmaceutical Holdings Limited (hereinafter “Lee’s Pharma”)(SEHK...
View ArticleClik here to view.
Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA)...
View ArticleClik here to view.
25家墨西哥医院承诺杜绝可预防死亡
加州尔湾 (美国商业资讯) — Javier Dávila Torres博士与11位墨西哥官员一起，在患者安全运动基金会(Patient Safety Movement Foundation,...
View ArticleClik here to view.
Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term...
OSAKA, Japan & LEUVEN, Belgium Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq:TIG) (“TiGenix”) today announced new data from the Phase 3...
View ArticleClik here to view.
メキシコの病院25軒が予防可能な死亡の根絶を誓約
米カリフォルニア州アーバイン （ビジネスワイヤ） — 患者安全運動財団（PSMF）の世界患者安全・科学・技術サミットにて、Dr. Javier Dávila...
View ArticleClik here to view.
ミネルヴァ・バイオテクノロジーズがナイーブ型幹細胞培養システムのAlphaSTEM™を発売
米マサチューセッツ州ウォルサム （ビジネスワイヤ） — がん治療および再生医療の分野における一流企業のミネルヴァ・バイオテクノロジーズは本日、AlphaSTEM™培養システムの市場投入を発表しました。このシステムは、胚形成の最初期に内部細胞塊のナイーブ細胞内のみで発現する新発見の成長因子を使用しています。...
View ArticleClik here to view.
Approval for Listing of Shares of Solasia on the Tokyo Stock Exchange Mothers
TOKYO Solasia Pharma K.K. (Headquarters: Tokyo, Japan, President and CEO: Yoshihiro Arai, hereinafter “Solasia”) an oncology specialized pharmaceutical company developing oncology products for Asian...
View ArticleClik here to view.
Initial Results Positive for CelGro® in Human Nerve Regeneration
PERTH, Australia Regenerative medicine company Orthocell is pleased to announce positive initial safety and tolerability results for its CelGro® collagen-based medical device, in a clinical study...
View ArticleClik here to view.
Truxima™, the first biosimilar mAb in oncology, granted EU marketing...
INCHEON, South Korea Celltrion Healthcare today announced that the European Commission has approved Truxima™ (biosimilar rituximab) for all indications of reference rituximab in the European Union...
View ArticleClik here to view.
サンバイオの脳梗塞に対する幹細胞治療が米国心臓協会からイノベーション・アワードを受賞
米カリフォルニア州マウンテンビュー （ビジネスワイヤ） — 神経系疾患を対象に再生細胞薬の開発・製造を手掛ける当社グループ（サンバイオ株式会社及びその子会社であるSanBio, Inc.） は、米国心臓協会（American Heart Association）の発行する医療専門誌Strokeで論文発表された骨髄由来間葉系幹細胞を使った脳梗塞治験フェーズ1/2a（本試験）について、2016...
View ArticleClik here to view.
Study of SanBio’s Stem Cell Treatment for Stroke Receives Innovation Award...
MOUNTAIN VIEW, Calif. SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, today announced that a recent publication of its novel stem cell treatment, SB623, for...
View ArticleClik here to view.
joimax® Obtains Full Product Registration in Thailand, and is Now Active in...
IRVINE, Calif. joimax® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding...
View ArticleClik here to view.
Baxter and ScinoPharm Announce Exclusive Strategic Partnership for Generic...
DEERFIELD, Ill. & TAINAN, Taiwan Baxter International Inc. (NYSE: BAX) and ScinoPharm Taiwan, Ltd. (TWSE: 1789) today announced a strategic partnership to develop, manufacture and commercialize...
View ArticleClik here to view.
新研究评估Masimo PVi®监测在结直肠手术中的功用
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布近期一项在低危结直肠手术患者中开展的研究的结果，研究人员在该研究中评估Masimo PVi®（脉搏灌注变异指数）无创连续监测在指导补液管控中的功用，并与创伤性的监测方法食管多普勒相比较。研究人员未发现这两种技术的平均总补液量有显著差异，因此断言，“PVi可为该组患者目的为导向治疗提供完全无创替代方法。1”...
View ArticleClik here to view.
Invenra and QIMR Berghofer Medical Research Institute Enter Collaboration to...
MADISON, Wis. & HERSTON, Australia Invenra, Inc., a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies, bispecifics and antibody derivatives,...
View ArticleClik here to view.
Avita Medical Named to 2017 OTCQX Best 50
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England Avita Medical Limited (ASX:AVH) (OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects,...
View ArticleClik here to view.
US Medical Device Company Visioneering Technologies, Inc. to List On ASX –...
ALPHARETTA, Georgia Visioneering Technologies, Inc. (VTI), a US based medical device company, is pleased to announce the opening of its fully underwritten Initial Public Offering (IPO) to raise...
View ArticleClik here to view.
EFIL Center Is Attracting Overseas Patients to Its Exophthalmos Center, Korea
DAEGU, South Korea JCI(Joint Commission International)-accredited EFIL Plastic Surgery is drawing attention across the globe with its exophthalmos surgery. This Smart News Release features...
View ArticleClik here to view.
Mauna Kea Technologies: Superiority of Endomicroscopy for the Diagnosis of...
PARIS Regulatory News: Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced...
View ArticleClik here to view.
The UK High Court of Justice (Patents) Rules in Fujifilm Kyowa Kirin...
TOKYO FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. (President and CEO: Hideaki Nomura; “Fujifilm Kyowa Kirin Biologics”) today announced that on March 3, 2017, the UK High Court of Justice ruled in...
View Article